Advertisement

Effective blood hemoglobin level to predict prognosis in heart failure with preserved left ventricular ejection fraction: results of the Japanese heart failure syndrome with preserved ejection fraction registry

  • Keisuke Okuno
  • Yoshiro NaitoEmail author
  • Masanori Asakura
  • Masataka Sugahara
  • Tomotaka Ando
  • Seiki Yasumura
  • Toshiyuki Nagai
  • Yoshihiko Saito
  • Tsutomu Yoshikawa
  • Tohru Masuyama
  • Toshihisa Anzai
Original Article
  • 31 Downloads

Abstract

High prevalence of anemia in heart failure with preserved left ventricular ejection fraction (HFpEF) has been reported. However, little is known about the association of anemia and gender with prognosis in HFpEF patients. In addition, effective blood hemoglobin (Hb) level for prognosis in HFpEF patients remains largely unknown. In this study, we investigated the association between anemia, gender, and prognosis in 535 HFpEF patients enrolled in Japanese heart failure syndrome with preserved ejection fraction registry. Furthermore, we assessed effective blood Hb level to predict prognosis in HFpEF patients. According to the World Health Organization criteria, the prevalence rate of anemia on admission was about 70% in both male and female HFpEF patients. Kaplan–Meier analysis for all-cause mortality demonstrated that anemic patients had poor prognosis compared with non-anemic patients in both male and female HFpEF patients. Interestingly, multivariate analysis revealed that blood Hb level at discharge was an independent predictor of all-cause mortality in both male and female HFpEF patients. According to survival classification and regression tree analysis, blood Hb level at discharge of 9.4 g/dL for male and 12.3 g/dL for female was more accurate cutoff value to predict all-cause mortality in HFpEF patients. Anemia was implicated in poor prognosis in both male and female HFpEF patients. In particular, blood Hb level at discharge was an independent predictor of all-cause mortality in both male and female HFpEF patients. Effective cutoff value of blood Hb level at discharge to predict all-cause mortality was lower in male than in female HFpEF patients.

Keywords

Anemia Hemoglobin Heart failure with preserved left ventricular ejection fraction 

Notes

Acknowledgements

We gratefully thank the contributions of all the investigators, clinical research coordinators, data managers, and laboratory technicians in the JASPER registry. This work was supported by a grant from the Japan Cardiovascular Research Foundation (T.A., 24-4-2).

Compliance with ethical standards

Conflict of interest

The authors declare that there is no conflict of interest.

References

  1. 1.
    O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Lang CC, Roger SD, Young JB, Solomon SD, Granger CB, Ostergren J, Olofsson B, Michelson EL, Pocock S, Yusuf S, Swedberg K, Pfeffer MA, CHARM Committees and Investigators (2006) Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Circulation 113:986–994CrossRefGoogle Scholar
  2. 2.
    Felker GM, Shaw LK, Stough WG, O'Connor CM (2006) Anemia in patients with heart failure and preserved systolic function. Am Heart J 151:457–462CrossRefGoogle Scholar
  3. 3.
    Latado AL, Passos LC, Darzé ES, Lopes AA (2006) Comparison of the effect of anemia on in-hospital mortality in patients with versus without preserved left ventricular ejection fraction. Am J Cardiol 98:1631–1634CrossRefGoogle Scholar
  4. 4.
    Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer P (2008) Anemia and mortality in heart failure patients: a systematic review and meta-analysis. J Am Coll Cardiol 52:818–827CrossRefGoogle Scholar
  5. 5.
    Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG (2006) Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the anemia in chronic heart failure: outcomes and resource utilization (ANCHOR) study. Circulation 113:2713–2723CrossRefGoogle Scholar
  6. 6.
    Silverberg DS, Wexler D, Iaina A, Schwartz D (2008) The role of correction of anaemia in patients with congestive heart failure: a short review. Eur J Heart Fail 10:819–823CrossRefGoogle Scholar
  7. 7.
    Okonko DO, Anker SD (2004) Anemia in chronic heart failure: pathogenetic mechanisms. J Cardiac Fail 10:S5–S9CrossRefGoogle Scholar
  8. 8.
    Anand IS (2008) Anemia and chronic heart failure: implications and treatment options. J Am Coll Cardiol 52:501–511CrossRefGoogle Scholar
  9. 9.
    Silverberg D, Wexler D, Blum M, Wollman Y, Iaina A (2003) The cardio-renal anemia syndrome: does it exist? Nephrol Dial Transpl 18 Suppl 8:viii:7–12Google Scholar
  10. 10.
    Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, Tu JV, Levy D (2009) Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham heart study of the national heart, lung, and blood institute. Circulation 119:3070–3077CrossRefGoogle Scholar
  11. 11.
    Nagai T, Yoshikawa T, Saito Y, Takeishi Y, Yamamoto K, Ogawa H, Anzai T, JASPER Investigators (2018) Clinical characteristics, management, and outcomes of Japanese patients hospitalized for heart failure with preserved ejection fraction: a report from the Japanese Heart Failure Syndrome with Preserved Ejection Fraction (JASPER) registry. Circ J 82:1534–1545CrossRefGoogle Scholar
  12. 12.
    McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441–1446CrossRefGoogle Scholar
  13. 13.
    World Health Organization (1968) Nutritional anaemias. Report of a WHO Scientific Group. WHO Techn Rep Ser 405:9–10Google Scholar
  14. 14.
    Leshem-Rubinow E, Steinvil A, Zeltser D, Berliner S, Rogowski O, Raz R, Chodick G, Shalev V (2012) Association of angiotensin-converting enzyme inhibitor therapy initiation with a reduction in hemoglobin levels in patients without renal failure. Mayo Clin Proc 87:1189–1195CrossRefGoogle Scholar
  15. 15.
    Humpeler E, Amor H (1973) Sex differences in the oxygen affinity of hemoglobin. Pflug Arch 343:151–156CrossRefGoogle Scholar
  16. 16.
    Roy CN, Snyder PJ, Stephens-Shields AJ, Artz AS, Bhasin S, Cohen HJ, Farrar JT, Gill TM, Zeldow B, Cella D, Barrett-Connor E, Cauley JA, Crandall JP, Cunningham GR, Ensrud KE, Lewis CE, Matsumoto AM, Molitch ME, Pahor M, Swerdloff RS, Cifelli D, Hou X, Resnick SM, Walston JD, Anton S, Basaria S, Diem SJ, Wang C, Schrier SL, Ellenberg SS (2017) Association of testosterone levels with anemia in older men: a controlled clinical trial. JAMA Intern Med 177:480–490CrossRefGoogle Scholar

Copyright information

© Springer Japan KK, part of Springer Nature 2019

Authors and Affiliations

  • Keisuke Okuno
    • 1
  • Yoshiro Naito
    • 1
    Email author
  • Masanori Asakura
    • 1
  • Masataka Sugahara
    • 1
  • Tomotaka Ando
    • 1
  • Seiki Yasumura
    • 1
  • Toshiyuki Nagai
    • 2
    • 3
  • Yoshihiko Saito
    • 4
  • Tsutomu Yoshikawa
    • 5
  • Tohru Masuyama
    • 1
  • Toshihisa Anzai
    • 2
    • 3
  1. 1.Cardiovascular Division, Department of Internal MedicineHyogo College of MedicineNishinomiyaJapan
  2. 2.Department of Cardiovascular MedicineHokkaido University Graduate School of MedicineSapporoJapan
  3. 3.Department of Cardiovascular MedicineNational Cerebral and Cardiovascular CenterOsakaJapan
  4. 4.Department of Cardiovascular MedicineNara Medical UniversityNaraJapan
  5. 5.Department of CardiologySakakibara Heart InstituteTokyoJapan

Personalised recommendations